The extract also showed promise in treating benign prostatic hypertrophy (BPH) reducing the proliferation and migration rates of BPH-1 cells by up to 60%, along with a decrease in the release of inflammatory cytokines such as IL-6 and PGE2, as well as pro-angiogenic factors like VEGF. This evidence concerns the gene VEGFA and benign prostatic hyperplasia.